Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20091113rdf:typepubmed:Citationlld:pubmed
pubmed-article:20091113lifeskim:mentionsumls-concept:C1708335lld:lifeskim
pubmed-article:20091113lifeskim:mentionsumls-concept:C0011812lld:lifeskim
pubmed-article:20091113lifeskim:mentionsumls-concept:C0114838lld:lifeskim
pubmed-article:20091113lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:20091113lifeskim:mentionsumls-concept:C0304402lld:lifeskim
pubmed-article:20091113lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:20091113lifeskim:mentionsumls-concept:C1420213lld:lifeskim
pubmed-article:20091113lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:20091113lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:20091113pubmed:issue2lld:pubmed
pubmed-article:20091113pubmed:dateCreated2010-3-1lld:pubmed
pubmed-article:20091113pubmed:abstractTextIndividuals vary in their subjective responses to stimulant drugs, and these differences are believed to be partially genetic in origin. We evaluated associations between mood, cognitive and cardiovascular responses to d-amphetamine and four polymorphisms in the dopamine transporter (SLC6A3): rs460000, rs3756450, rs37022 and rs6869645. Healthy Caucasian male and female volunteers (N = 152) participated in a double-blind, crossover design study in which they received placebo, 10 and 20 mg of d-amphetamine. We measured self-reported rating of mood, performance on the Digit Symbol Substitution Task, blood pressure and heart rate. Individuals with the C/C genotype at rs460000 (N = 83) reported approximately twofold higher ratings of stimulation and euphoria relative to the A/A+A/C (N = 69) genotype group, at both the 10 and 20 mg doses. No other responses or SNPs showed significant effects. rs460000 is in perfect LD with rs463379 (CEU: D' = 1; r (2) = 1), which was not studied here, but has been associated with etiology of Attention Deficit Hyperactivity Disorder (ADHD). These findings suggest a pleiotropic effect of this polymorphic locus on both ADHD and sensitivity to the subjective effects of amphetamine.lld:pubmed
pubmed-article:20091113pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:languageenglld:pubmed
pubmed-article:20091113pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:citationSubsetIMlld:pubmed
pubmed-article:20091113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20091113pubmed:statusMEDLINElld:pubmed
pubmed-article:20091113pubmed:monthMarlld:pubmed
pubmed-article:20091113pubmed:issn1573-3297lld:pubmed
pubmed-article:20091113pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:20091113pubmed:authorpubmed-author:PalmerAbraham...lld:pubmed
pubmed-article:20091113pubmed:authorpubmed-author:DlugosAndreaAlld:pubmed
pubmed-article:20091113pubmed:authorpubmed-author:HamidovicAjna...lld:pubmed
pubmed-article:20091113pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20091113pubmed:volume40lld:pubmed
pubmed-article:20091113pubmed:ownerNLMlld:pubmed
pubmed-article:20091113pubmed:authorsCompleteYlld:pubmed
pubmed-article:20091113pubmed:pagination255-61lld:pubmed
pubmed-article:20091113pubmed:dateRevised2011-9-22lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:meshHeadingpubmed-meshheading:20091113...lld:pubmed
pubmed-article:20091113pubmed:year2010lld:pubmed
pubmed-article:20091113pubmed:articleTitlePolymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.lld:pubmed
pubmed-article:20091113pubmed:affiliationThe University of Chicago, Chicago, IL, USA.lld:pubmed
pubmed-article:20091113pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20091113pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20091113pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:6531entrezgene:pubmedpubmed-article:20091113lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20091113lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20091113lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20091113lld:pubmed